首页> 美国卫生研究院文献>Journal of Pharmaceutical Health Care and Sciences >Low concentrations of clarithromycin upregulate cellular antioxidant enzymes and phosphorylation of extracellular signal-regulated kinase in human small airway epithelial cells
【2h】

Low concentrations of clarithromycin upregulate cellular antioxidant enzymes and phosphorylation of extracellular signal-regulated kinase in human small airway epithelial cells

机译:低浓度的克拉霉素可上调人小气道上皮细胞中的细胞抗氧化酶和细胞外信号调节激酶的磷酸化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundIt is well known that low-dose, long-term macrolide therapy is effective against chronic inflammatory airway diseases. Oxidative stress is considered to be a key pathogenesis factor in those diseases. However, the mechanism of action of low-dose, long-term macrolide therapy remains unclear. We have reported that clarithromycin (CAM), which is a representative macrolide antibiotic, could inhibit hydrogen peroxide (H2O2)-induced reduction of the glutathione (GSH)/glutathione disulfide (GSSG) ratio in human small airway epithelial cells (SAECs), via the maintenance of GSH levels through an effect on γ-glutamylcysteine synthetase (γ-GCS) expression. In this study, we examined the influence of CAM against H2O2-induced activities of cellular antioxidant enzymes and phosphorylated extracellular signal regulatory kinase (p-ERK) using SAECs, the main cells involved in chronic airway inflammatory diseases.
机译:背景技术众所周知,低剂量,长期大环内酯类药物疗法可有效治疗慢性炎症性气道疾病。氧化应激被认为是这些疾病的关键发病机理。然而,低剂量,长期大环内酯类药物治疗的作用机制仍不清楚。我们已经报道了代表性的大环内酯类抗生素克拉霉素(CAM)可以通过以下途径抑制过氧化氢(H2O2)诱导的人小气道上皮细胞(SAECs)中的谷胱甘肽(GSH)/谷胱甘肽二硫化物(GSSG)比率降低。通过影响γ-谷氨酰半胱氨酸合成酶(γ-GCS)的表达来维持GSH水平。在这项研究中,我们使用了SAEC(主要参与慢性气道炎性疾病的主要细胞)研究了CAM对H2O2诱导的细胞抗氧化剂酶和磷酸化细胞外信号调节激酶(p-ERK)活性的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号